Condensed Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total		Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain/(Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023			59,921,002
Beginning balance at Dec. 31, 2023	$ 473,576		$ 6	$ 972,973	$ 345	$ (499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			397,540
Issuance of common stock under benefit plans	1,879			1,879
Stock-based compensation expense	9,666			9,666
Net unrealized loss on short-term investments	(834)				(834)
Net loss	(46,955)					(46,955)
Ending balance (in shares) at Mar. 31, 2024			60,318,542
Ending balance at Mar. 31, 2024	$ 437,332		$ 6	984,518	(489)	(546,703)
Beginning balance (in shares) at Dec. 31, 2024	60,860,838		60,860,838
Beginning balance at Dec. 31, 2024	$ 304,081	[1]	$ 6	1,013,806	321	(710,052)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			525,345
Issuance of common stock under benefit plans	498			498
Stock-based compensation expense	8,913			8,913
Net unrealized loss on short-term investments	(162)				(162)
Net loss	$ (56,166)					(56,166)
Ending balance (in shares) at Mar. 31, 2025	61,386,183		61,386,183
Ending balance at Mar. 31, 2025	$ 257,164		$ 6	$ 1,023,217	$ 159	$ (766,218)

[1] The condensed balance sheet as of December 31, 2024 has been derived from the audited financial statements as of that date.